Richard Nolan Townsend Lexeo Therapeutics, Inc. (LXEO) insider trading activity

Shares Held (Direct Ownership) 121K

29.29% 3M change

n/a 12M change

Total Value Held N/A

Richard Nolan Townsend Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2024	SELL Open market or private sale	$53,250 $10.65 p/Share	5,000 Reduced 3.98%	120,695 Common Stock
Sep 10 2024	BUY Exercise of conversion of derivative security	$11,650 $2.33 p/Share	5,000 Added 3.83%	125,695 Common Stock
Aug 12 2024	SELL Open market or private sale	$57,650 $11.53 p/Share	5,000 Reduced 3.98%	120,695 Common Stock
Aug 12 2024	BUY Exercise of conversion of derivative security	$11,650 $2.33 p/Share	5,000 Added 3.83%	125,695 Common Stock
Jul 11 2024	SELL Open market or private sale	$506,239 $18.06 p/Share	28,031 Reduced 18.85%	120,695 Common Stock
Jul 10 2024	SELL Open market or private sale	$449,033 $16.65 p/Share	26,969 Reduced 15.35%	148,726 Common Stock
Jul 10 2024	BUY Exercise of conversion of derivative security	$11,650 $2.33 p/Share	5,000 Added 2.77%	175,695 Common Stock
Jun 10 2024	SELL Open market or private sale	$88,699 $17.74 p/Share	5,000 Reduced 2.85%	170,695 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	$11,650 $2.33 p/Share	5,000 Added 2.77%	175,695 Common Stock
May 13 2024	SELL Open market or private sale	$66,100 $13.22 p/Share	5,000 Reduced 2.85%	170,695 Common Stock
May 13 2024	BUY Exercise of conversion of derivative security	$11,650 $2.33 p/Share	5,000 Added 2.77%	175,695 Common Stock
Jan 05 2024	BUY Grant, award, or other acquisition	-	43,750 Added 20.4%	170,695 Common Stock

RNT

Chief Executive Officer

New York, NY

Receive a notification when an Institution or Guru buys or sells LXEO shares.

Notify only if

Value

Get notified when an Lexeo Therapeutics, Inc. insider buys or sells LXEO shares.

Notify only if

Operation

Value

Type

Receive news related to Lexeo Therapeutics, Inc.